Study design

retrospective

Study time

2015.1-2016.12

Country

United Kingdom

Object

Patients with localised prostate cancer who under_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_went RARP

Inclusion criteria

patients with a history of prostate cancer treatment (n = 3), preoperative incontinence (n = 2), adjuvant therapy (n = 8), and missing follow-up data (n = 9). B

Sample size

190

Topic classification

MRI，Prediction，Atomic structure

Keypoint

This study confirmed the significance of membranous urethral length for the continence outcome following RARP.

Year